Role of calcium feedback in excitation-contraction coupling in isolated triads.
There is a considerable controversy in the literature concerning the effects of higher concentrations of calcium chelators (e.g. BAPTA (1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid) or fura-2) on the intracellular Ca2+ transients in muscle. We induced calcium release from sarcoplasmic reticulum (SR) in the triad preparation by chemical depolarization of the T-tubule in the presence of various concentrations of BAPTA-calcium buffer ([Ca2+] = 0.1 microM) and investigated the effects of the BAPTA concentration on the time courses of conformational changes in the junctional foot protein (JFP) and calcium release from SR. Upon stimulation, the JFP underwent biphasic conformational changes, as determined by stopped-flow fluorometry of the JFP-bound conformational probe. The first phase of protein conformational change, which preceded calcium release from SR, was virtually unaffected by the BAPTA concentration. However, the magnitude of the second phase increased in an inversely proportional fashion to the BAPTA concentration. An abrupt increase in [Ca2+] from 0.1 microM up to 1.0 microM (delta Ca2+), concurrently with T-tubule depolarization, produced biphasic protein conformational changes: a delta Ca(2+)-independent first phase and a delta Ca(2+)-dependent second phase. Similar Ca2+ jump experiments under non-depolarizing conditions produced a slow monophasic conformational change equivalent to the second phase described above. These results suggest that the first phase of protein conformational change represents the activation of JFP by T-tubule depolarization to induce calcium release, and the second phase the secondary activation by the released Ca2+. Activation of the JFP by the released Ca2+ resulted in an acceleration of both (i) the rate of initial calcium release, and (ii) the subsequent attenuation of calcium release. The acceleration of both was suppressed by higher concentrations of BAPTA. These results provide a reasonable explanation for both of the apparently contradictory views in the literature; high concentrations of calcium buffer (a) suppress the initial activation and (b) prevent the subsequent attenuation of calcium release.
Yano
M
M
Boston Biomedical Research Institute, Massachusetts 02114, USA.
el-Hayek
R
R
Ikemoto
N
N
D000818:Animals; D002118:Calcium / Q000378:metabolism*; D015220:Calcium Channels / Q000737:chemistry; D004533:Egtazic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D005246:Feedback; D066298:In Vitro Techniques; D007700:Kinetics; D008564:Membrane Potentials / Q000187:drug effects; D008954:Models, Biological; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology*; D009124:Muscle Proteins / Q000737:chemistry; D018482:Muscle, Skeletal / Q000187:drug effects / Q000502:physiology; D011487:Protein Conformation / Q000187:drug effects; D011817:Rabbits; D019837:Ryanodine Receptor Calcium Release Channel; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000378:metabolism*
D015220:Calcium Channels; D009124:Muscle Proteins; D019837:Ryanodine Receptor Calcium Release Channel; D004533:Egtazic Acid; C025603:1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; D002118:Calcium